It appears to be superior to standard antibody-based quality-control tests currently used for that purpose, but such scientific advances will need to undergo extensive validation studies before they can be considered a reliable predictor of effects in vivo and eliminate the need for clinical data.

FORBES: Do You Think 'Biosimilars' Will Reduce Healthcare Expenditures? Think again.

The validation workshops of the studies conducted on Senegal and Guinea-Bissau took place, respectively, on 2 and 3 October 2012, in Dakar, and on 27 and 28 November 2012 in Bissau.

UNESCO: MEDIA SERVICES